Navigation Links
Health Outcomes Data Essential to Biopharmaceutical Sales Process
Date:7/23/2010

CHAPEL HILL, N.C., July 23 /PRNewswire/ -- Sales executives agree that delivering health outcomes data is increasingly important in the biopharmaceutical sales process. Yet only 6 percent of district sales managers currently understand and often communicate this type of data to sales representatives.  

"DMs need knowledge of health outcomes, evidence based medicine and reimbursement," states an interviewed sales executive in "Trends and Future Directions for the High Performing District Sales Manager." Slightly more than half of companies are using laptop-based presentations to equip managers and reps to communicate health outcomes data to physicians.

"Trends and Future Directions for the High Performing District Sales Manager," a report derived from primary research conducted by Best Practices, LLC, identifies recent changes, new directions, and best practices for the current and future roles of district sales managers in driving superior sales productivity and growth.

Download a complimentary white paper at http://www3.best-in-class.com/rr1013.htm that includes selected best practices drawn from extensive primary research with 94 sales leaders from 46 different pharmaceutical and biotechnology companies across 24 different countries on six continents. Benchmark partners include Novartis, Roche, Abbott, GlaxoSmithKline, Bristol-Myers Squibb, sanofi-aventis, Merck, Takeda, Boehringer Ingelheim.

Key topics include:

  • Sales Force Growth & Reduction Drivers
  • Detailed Sales Model Changes
  • Physician Access Levels
  • Critical DM Activities & Trends in DM Responsibilities
  • Essential DM Management, Leadership & Competency Skills
  • Impact of Pharma Model Changes on DMs
  • Pharma Sales Rep Licensing
  • DM Readiness for Change

The full 73-page report contains more than 500 benchmark metrics and 47 executive narratives collected from two benchmarking studies conducted during the past three years, providing sales executives with longitudinal data about the shifts and developments of the roles and responsibilities of the influential DM.

For more information on this study or other recent primary research studies, contact us at 919.403.0251 or at bestpractices@best-in-class.com.  

BEST PRACTICES, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for more than 17 years; our clients include 48 out of the top 50 pharmaceutical companies.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CRF Health is Awarded for Getting Closer
2. Bayer HealthCare Pharmaceuticals Supports New Jersey Governors School in the Sciences at Drew University
3. Amicus CEO Represents BIO on Rare Diseases at U.S. Senate Committee on Health, Education, Labor and Pensions Bipartisan Hearing
4. ID Experts Announces RADAR™: A HITECH Risk Assessment Tool for Healthcare Security Breach Incidents Affecting Patient Privacy
5. AstraZeneca and Grace Hill Neighborhood Health Centers, Inc. Provide Medicines to Missouris Uninsured
6. Zimmer Holdings to Present at BMO Capital Markets Tenth Annual Focus on Healthcare Conference
7. Health Robotics CytoCare Continues European Expansion With Grifols and Vall dHebron University Hospital
8. BIO Ventures for Global Health Opens San Francisco Office; Hires New Senior Staff
9. Huntington Memorial Hospital Selects Allscripts Community Solution to Create a Connected, Collaborative Health Community
10. Hudson Valley Physician Testifies Before House Health Subcommittee Tuesday About Incentives for Adoption of Health Information Technology
11. MedWest Health System Selects Allscripts Electronic Health Record and Practice Management for Employed Physicians
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... , April 24, 2017 Solentim, ... today announced the addition of a major new ... In-situ Plate Seeding,). The VIPS has been developed ... 384 well microplates as part of the process ... offers a simple and more reliable solution when ...
(Date:4/20/2017)... PLANO, Texas , April 20, 2017  Vivify ... via mobile devices, has been awarded a very significant ... care via EMRs to continual care via digital health. ... of key intellectual property and further secures Vivify,s position ... Vivify, launched in 2009, was the first company to ...
(Date:4/20/2017)... , April 20, 2017  RXi Pharmaceuticals Corporation ... therapeutics that address significant unmet medical needs, today ... the Company,s consumer product development program, based on ... Society for Investigative Dermatology (SID) 76 th ... and promote the sciences relevant to skin health ...
Breaking Medicine Technology:
(Date:4/26/2017)... (PRWEB) , ... April 26, ... ... which provides an agile ecosystem and domain expertise for sponsors and CROs ... randomization and trial supply management (RTSM) software platform. Bioclinica AGILE RTSM ...
(Date:4/25/2017)... ... April 25, 2017 , ... Coalition ... for Duchenne muscular dystrophy, and funding for Duchenne research, congratulates Capricor Therapeutics ... HOPE clinical trial in Duchenne announced today. , Coalition Duchenne funded studies ...
(Date:4/25/2017)... ... April 25, 2017 , ... Lake Park Dental is now accepting new ... in Lutz, FL. With the help of this highly-effective, yet convenient system, patients ... complications, more discretion and less pain. , Drs. Sarah Jockin, Nicole Morganti, Sara ...
(Date:4/25/2017)... ... 2017 , ... Buyers and sellers in the thriving multi-billion dollar cannabis marketplace ... help but be heartened by the industry’s current surge. But another thing that unifies ... smell.” At last they can simply, safely and effectively end their aroma anguish ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... products, is introducing Flexadin UCII, part of the EQUISTRO line, at this week’s ... health in horses at the immunologic level. , The scientifically-developed Flexadin UCII supports ...
Breaking Medicine News(10 mins):